Advantis (OTC PINK: ADVT) CEO, Christopher Swartz, called in to SmallCapVoice.com, Inc. to discuss what his Company is working on 2016, the various markets they operate in and provides his personal insights to the exciting recent news for Advantis. Advantis Corporation (ADVT) develops products and works with developing companies to provide innovative healthcare products, holistic pain management solutions, and enhance the footprint in the evolving legal cannabis business. Advantis acquires ownership in developing companies that work within the nutraceutical and the alternative health care industries; consulting with these organizations to improve their product lines, expand their distribution channels through internal partnership agreements, and heighten brand value.
Recently Advantis announced that they engaged in a critical letter of intent with Hemp2Health, LLC, a Colorado company, to provide high grade CBD oil extract to Advantis for its product lines. Prior to that news they announced the hiring of Thomas Elgin, MD, as its Chief Medic. Dr. Elgin has worked in emergency medicine for fifteen years, and has extensive experience researching and developing nutraceuticals. CBD based nutraceuticals is the fastest growing sector within the medical marijuana business. Advantis CEO, Christopher Swartz says that Dr. Elgin will additionally be responsible for testing the efficacy of products Advantis acquires and distributes. Swartz shares the doctor’s excitement about the future of CBD technology. “I am passionate about finding effective solutions to cure this chronic pain epidemic,” Swartz stated. “Dr. Elgin has been working with me at Sequence Therapy to develop proper exercises, and now at Advantis we will work together to develop effective medicines.”
This interview may include forward looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this release. Although the Company believes that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof.